Invus Public Equities, L.P. Glycomimetics Inc (GLYC) insider trading activity

Invus Public Equities, L.P. is of GLYCOMIMETICS INC. Currently has a direct ownership of 6.32 Million shares of GLYC, which is worth approximately $1.45 Million. The most recent transaction as insider was on Aug 08, 2024, when has been sold 260,873 shares (Common Stock) at a price of $0.19 per share, resulting in proceeds of $49,565. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.32M

0% 3M change

26.45% 12M change

Total Value Held $1.45 Million

Invus Public Equities, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2024	SELL Open market or private sale	$49,565 $0.19 p/Share	260,873 Reduced 3.97%	6,317,565 Common Stock
Aug 07 2024	SELL Open market or private sale	$11,067 $0.18 p/Share	61,488 Reduced 0.93%	6,578,438 Common Stock
Aug 06 2024	SELL Open market or private sale	$10,031 $0.18 p/Share	55,732 Reduced 0.83%	6,639,926 Common Stock
Aug 05 2024	SELL Open market or private sale	$31,259 $0.19 p/Share	164,523 Reduced 2.4%	6,695,658 Common Stock
Aug 02 2024	SELL Open market or private sale	$57,240 $0.2 p/Share	286,200 Reduced 4.0%	6,860,181 Common Stock
Aug 01 2024	SELL Open market or private sale	$13,984 $0.22 p/Share	63,564 Reduced 0.88%	7,146,381 Common Stock
Jul 30 2024	SELL Open market or private sale	$166,503 $0.22 p/Share	756,835 Reduced 9.5%	7,209,945 Common Stock
Jul 29 2024	SELL Open market or private sale	$87,347 $0.24 p/Share	363,949 Reduced 4.37%	7,966,780 Common Stock
Jul 26 2024	SELL Open market or private sale	$62,000 $0.24 p/Share	258,335 Reduced 3.01%	8,330,729 Common Stock
Feb 24 2023	BUY Open market or private purchase	$170,000 $1.7 p/Share	100,000 Added 1.15%	8,589,064 Common Stock
Feb 23 2023	BUY Open market or private purchase	$350,000 $1.75 p/Share	200,000 Added 2.3%	8,489,064 Common Stock
Feb 22 2023	BUY Open market or private purchase	$268,500 $1.79 p/Share	150,000 Added 1.78%	8,289,064 Common Stock
Feb 21 2023	BUY Open market or private purchase	$92,500 $1.85 p/Share	50,000 Added 0.61%	8,139,064 Common Stock
Feb 17 2023	BUY Open market or private purchase	$340,000 $1.7 p/Share	200,000 Added 2.41%	8,089,064 Common Stock
Feb 16 2023	BUY Open market or private purchase	$529,646 $1.68 p/Share	315,266 Added 3.84%	7,889,064 Common Stock
Feb 15 2023	BUY Open market or private purchase	$2,160,000 $2.16 p/Share	1,000,000 Added 11.66%	7,573,798 Common Stock
Feb 09 2023	BUY Open market or private purchase	$37,101 $3.24 p/Share	11,451 Added 0.17%	6,573,798 Common Stock

Also insider at

SEER

Seer, Inc. Healthcare

> 10% Shareholder

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

LXRX

LEXICON PHARMACEUTICALS, INC. Healthcare

Director

SRRK

Scholar Rock Holding Corp Healthcare

OMGA

Omega Therapeutics, Inc. Healthcare

> 10% Shareholder

SQZ

SQZ Biotechnologies Co Healthcare

> 10% Shareholder

IPE